In the constant pursuit to improve outcomes, we join in service with physicians to engineer powerful products and form empowering partnerships. This is our deep commitment to innovation that the aortic medical community has relied on and can continue to count on now and in the future.
The only AAA device that is infrarenal by design, intended to help mitigate the risks associated with suprarenal fixation devices.
“Stent grafts with active fixation below the renal arteries as well as oversizing by less than 10% seem to have the least effect on aortic neck degeneration over time…”
Featuring angulation control for optimal seal
Evolving TEVAR:
Vascular Surgeon shares his experience with TEVAR device
The only FDA approved Iliac branch device
We have multiple clinical and investigational trials in process, supporting a robust aortic pipeline.
Our commitment to lifelong innovation
- Kay B. Active stent-graft fixation below the renal arteries may have the least effect on aortic neck degeneration, study finds. Vascular Specialist -Society for Vascular Surgery (SVS) website. Posted November 17, 2020. Accessed December 2, 2020.
* Three year follow-up of U.S. IDE Clinical Trial for all patients from primary enrollment (n = 63)